Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	82.52	39.77	21.79
Graham Fair Price	-1.49	22.42	22.76
PEG	183.47	-2.06	0.73
Price/Book	2.75	0.97	0.95
Price/Cash Flow	119.01	-24.79	11.32
Prices/Earnings	10.66	11.12	10.05
Price/Sales	3.92	0.91	0.87
Price/FCF	119.01	-24.79	11.32
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-2.85	0.11	0.11
Operating Margin	-32.11	0.02	0.04
ROA	-11.10	< 0.005	< 0.005
ROE	0.02	0.02	-7.16
ROIC	0.02	0.01	-31.81
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.04	1.03	-96.36
Dividends QOQ	-0.94	12.42	1215.19
EBIT QOQ	0.28	-0.31	10.61
EPS QOQ	0.14	-0.05	-60.96
FCF QOQ	17.02	-1.48	-91.31
Revenue QOQ	0.04	0.01	-69.66
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	42.86	43.60	1.75
Days Sales Outstanding (DSO)	101.52	119.70	17.91
Inventory Turnover	2.10	2.06	-1.72
Debt/Capitalization	0.44	0.44	0.83
Quick Ratio	1.14	1.12	-1.78
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	31.29	31.99	2.23
Cash	11.68	10.28	-11.98
Capex	-0.18	-0.13	26.52
Free Cash Flow	2.61	-1.25	-52.04
Revenue	33.86	34.22	1.07
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.49	1.44	-3.30
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.66	13.15	97.43
Naive Interpretation	Member

06 - Financial Health · Weak

Rating